429 related articles for article (PubMed ID: 26321629)
1. Changes of orbital tissue volumes and proptosis in patients with thyroid extraocular muscle swelling after methylprednisolone pulse therapy.
Higashiyama T; Nishida Y; Ohji M
Jpn J Ophthalmol; 2015 Nov; 59(6):430-5. PubMed ID: 26321629
[TBL] [Abstract][Full Text] [Related]
2. Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy.
Higashiyama T; Nishida Y; Morino K; Ugi S; Nishio Y; Maegawa H; Ohji M
Jpn J Ophthalmol; 2015 Mar; 59(2):124-30. PubMed ID: 25448468
[TBL] [Abstract][Full Text] [Related]
3. Significance of orbital fatty tissue for exophthalmos in thyroid-associated ophthalmopathy.
Nishida Y; Tian S; Isberg B; Hayashi O; Tallstedt L; Lennerstrand G
Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):515-20. PubMed ID: 12136278
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
[TBL] [Abstract][Full Text] [Related]
5. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis.
Kvetny J; Puhakka KB; Røhl L
Acta Ophthalmol Scand; 2006 Jun; 84(3):419-23. PubMed ID: 16704711
[TBL] [Abstract][Full Text] [Related]
8. Orbital fat decompression for thyroid eye disease: retrospective case review and criteria for optimal case selection.
Prat MC; Braunstein AL; Dagi Glass LR; Kazim M
Ophthalmic Plast Reconstr Surg; 2015; 31(3):215-8. PubMed ID: 25198394
[TBL] [Abstract][Full Text] [Related]
9. Effect of high-dose intravenous steroid pulse therapy followed by 3-month oral steroid therapy for Graves' ophthalmopathy.
Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
Jpn J Ophthalmol; 2002; 46(5):563-7. PubMed ID: 12457917
[TBL] [Abstract][Full Text] [Related]
10. Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.
Hou K; Ai T; Hu WK; Luo B; Wu YP; Liu R
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):938-942. PubMed ID: 29270757
[TBL] [Abstract][Full Text] [Related]
11. Semi-automatic volume measurement for orbital fat and total extraocular muscles based on Cube FSE-flex sequence in patients with thyroid-associated ophthalmopathy.
Tang X; Liu H; Chen L; Wang Q; Luo B; Xiang N; He Y; Zhu W; Zhang J
Clin Radiol; 2018 Aug; 73(8):759.e11-759.e17. PubMed ID: 29804628
[TBL] [Abstract][Full Text] [Related]
12. High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy.
Kauppinen-Mäkelin R; Karma A; Leinonen E; Löyttyniemi E; Salonen O; Sane T; Setälä K; Viikari J; Heufelder A; Välimäki M
Acta Ophthalmol Scand; 2002 Jun; 80(3):316-21. PubMed ID: 12059873
[TBL] [Abstract][Full Text] [Related]
13. The role of intravenous methylprednisolone immunosuppression in the management of active thyroid eye disease.
Tambe K; Bhargava J; Tripathi A; Gregory M; Burns J; Sampath R
Orbit; 2010 Oct; 29(5):227-31. PubMed ID: 20812826
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of extraocular muscle volume and exophthalmos reduction after radiation therapy to treat Graves' ophthalmopathy: A pilot study.
Kim M; Chang JH; Lee NK
Eur J Ophthalmol; 2021 Mar; 31(2):340-345. PubMed ID: 31496266
[TBL] [Abstract][Full Text] [Related]
15. [Intraocular pressure after treatment for thyroid-associated ophthalmopathy].
Crespí J; Rodríguez F; Buil JA
Arch Soc Esp Oftalmol; 2007 Nov; 82(11):691-6. PubMed ID: 17979037
[TBL] [Abstract][Full Text] [Related]
16. Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy.
Choi SW; Lee JY; Lew H
Korean J Ophthalmol; 2016 Feb; 30(1):1-9. PubMed ID: 26865797
[TBL] [Abstract][Full Text] [Related]
17. Clinical challenge: An orbital Hickam's dictum.
Wilson ME; Thornton S; Murchison AP; Bilyk JR
Surv Ophthalmol; 2016; 61(6):799-805. PubMed ID: 26994869
[TBL] [Abstract][Full Text] [Related]
18. The application of temperature measurement of the eyes by digital infrared thermal imaging as a prognostic factor of methylprednisolone pulse therapy for Graves' ophthalmopathy.
Shih SR; Li HY; Hsiao YL; Chang TC
Acta Ophthalmol; 2010 Aug; 88(5):e154-9. PubMed ID: 20553230
[TBL] [Abstract][Full Text] [Related]
19. A quantitative analysis of orbital soft tissue in Graves' disease based on B-mode ultrasonography.
Yamamoto K; Itoh K; Yoshida S; Saito K; Sakamoto Y; Matsuda A; Saito T; Kuzuya T
Endocrinol Jpn; 1979 Apr; 26(2):255-61. PubMed ID: 582582
[TBL] [Abstract][Full Text] [Related]
20. Thyroid-associated inferior oblique myopathy.
Kakizaki H; Zako M; Iwaki M
Ophthalmology; 2007 Nov; 114(11):2106. PubMed ID: 17980760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
